Roslyn E. Wallace
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
-
- Cancer Treatment and Pharmacology
Papers in
-
- Animal Virus Infections Studies 3
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Polyomavirus and related diseases 3
- Co-authors
- Frederick E. DurrK. C. MurdockRobert B. AngierR. V. CitarellaP. F. FABIORalph G. ChildJohn C. PetriccianiDouglas E. Lorenz
- Journals
- JNCI Journal of the National Cancer Institute (5 papers)Nature (3 papers)Science (1 paper)Journal of Medicinal Chemistry (1 paper)Experimental Cell Research (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Roslyn E. Wallace
19 papers receiving 577 citations
Peers
Comparison fields: 5 of 77
- Toxicology 95
- Oncology 194
- Bioengineering 28
- Molecular Biology 308
- Animal Science and Zoology 38
Countries citing papers authored by Roslyn E. Wallace
This map shows the geographic impact of Roslyn E. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roslyn E. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roslyn E. Wallace more than expected).
Fields of papers citing papers by Roslyn E. Wallace
This network shows the impact of papers produced by Roslyn E. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roslyn E. Wallace. The network helps show where Roslyn E. Wallace may publish in the future.
Co-authorship network
The 20 scholars most cited alongside Roslyn E. Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 6 | |
| 2 | 1987 | 18 | |
| 3 | 1984 | 15 | |
| 4 | Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. | 1982 | 27 |
| 5 | Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice. | 1979 | 134 |
| 6 | 1979 | 244 | |
| 7 | 1976 | 5 | |
| 8 | A comparison of three in vivo assays for cell tumorigenicity. | 1974 | 12 |
| 9 | 1973 | 30 | |
| 10 | 1973 | 12 | |
| 11 | 1973 | 49 | |
| 12 | 1972 | 5 | |
| 13 | 1971 | 30 | |
| 14 | 1967 | 7 | |
| 15 | 1964 | 36 | |
| 16 | 1963 | 2 | |
| 17 | 1961 | 9 | |
| 18 | 1961 | 6 | |
| 19 | 1958 | 7 |
About Roslyn E. Wallace
Roslyn E. Wallace is a scholar working on Animal Science and Zoology, Oncology, Immunology, Biotechnology and Genetics, having authored 19 papers that have together received 654 indexed citations. Recurring topics across this work include Virus-based gene therapy research (6 papers), Cancer Treatment and Pharmacology (3 papers), Animal Virus Infections Studies (3 papers), Polyomavirus and related diseases (3 papers), Cancer therapeutics and mechanisms (3 papers), Glycosylation and Glycoproteins Research (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Toxicology (95 citations), Oncology (194 citations), Bioengineering (28 citations), Molecular Biology (308 citations) and Animal Science and Zoology (38 citations). Roslyn E. Wallace has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Frederick E. Durr, K. C. Murdock, Robert B. Angier, R. V. Citarella, P. F. FABIO, Ralph G. Child, John C. Petricciani, Douglas E. Lorenz, Hope E. Hopps and Herald R. Cox. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Nature, Science, Journal of Medicinal Chemistry and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.